|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 11.87 USD | +0.34% |
|
-7.12% | +54.16% |
| 08-12 | B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating | MT |
| 08-11 | Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat | MT |
| Market Cap | 416M 360M 338M 307M 578M 39.88B 587M 3.97B 1.55B 19.95B 1.56B 1.53B 66.44B | P/E 2026 * |
36.8x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 416M 360M 338M 307M 578M 39.88B 587M 3.97B 1.55B 19.95B 1.56B 1.53B 66.44B | EV / Sales 2026 * |
5.71x | EV / Sales 2027 * | 4.04x |
| Free-Float |
80.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc.
| 1 day | +0.34% | ||
| 1 week | -7.12% | ||
| Current month | +24.03% | ||
| 1 month | +13.05% | ||
| 3 months | +23.65% | ||
| 6 months | +32.33% | ||
| Current year | +54.16% |
| 1 week | 11.65 |  | 12.35 |
| 1 month | 9.4 | | 13.25 |
| Current year | 5.65 | | 13.25 |
| 1 year | 5.65 | | 13.25 |
| 3 years | 3.96 | | 13.25 |
| 5 years | 3.82 | | 13.25 |
| 10 years | 1.64 | | 14.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Buy | Chief Technology Officer | 168 | 0.0005% | ||
| 8/3/26 | Buy | Executive/Senior Manager | 168 | 0.0005% | ||
| 8/3/26 | Sell | -10,000 | 0.0288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -7.12% | +44.76% | +51.60% | 416M | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,093B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 653B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 458B | |
| +1.09% | -0.03% | +40.43% | +43.69% | 355B | |
| +0.43% | +1.67% | +25.15% | +40.31% | 294B | |
| +0.85% | +1.97% | +1.28% | +11.79% | 248B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 230B | |
| -0.73% | -1.69% | -15.40% | -53.31% | 203B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 178B | |
| Average | +1.06% | +0.37% | +31.79% | +49.95% | 371.09B | |
| Weighted average by Cap. | +1.10% | +1.45% | +43.80% | +68.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.9M 62.96M 59.24M 53.84M 101M 6.98B 103M 695M 272M 3.49B 274M 268M 11.64B | 103M 89.09M 83.82M 76.19M 143M 9.88B 145M 983M 385M 4.94B 387M 379M 16.46B |
| Net income | 11.25M 9.71M 9.14M 8.31M 15.62M 1.08B 15.85M 107M 42.01M 539M 42.22M 41.31M 1.8B | 35.24M 30.43M 28.63M 26.02M 48.95M 3.38B 49.66M 336M 132M 1.69B 132M 129M 5.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | US$11.87 | +0.34% | 129,513 |
| 26-08-17 | US$11.83 | +0.94% | 190,570 |
| 26-08-14 | US$11.72 | -2.82% | 106,941 |
| 26-08-13 | US$12.06 | +1.94% | 191,018 |
| 26-08-12 | US$11.83 | -7.43% | 358,942 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FENC Stock
Select your edition
All financial news and data tailored to specific country editions
